(Q44612105)

4 December 2017

title

Corticosteroid use and risk of hip fracture: a population-based case-control study in Denmark (English)

1 reference

4 December 2017

0 references

1 reference

4

1 reference

4 December 2017

P Vestergaard

1

1 reference

4 December 2017

M L Olsen

2

1 reference

4 December 2017

S Paaske Johnsen

3

1 reference

4 December 2017

H Toft Sørensen

5

1 reference

4 December 2017

L Mosekilde

6

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

Journal of Internal Medicine

4 December 2017

published in

1 reference

4 December 2017

volume

254

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

486-493

1 reference

Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01219.X

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01219.X

The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01219.X

Inhaled corticosteroids and hip fracture: a population-based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01219.X

Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01219.X

Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01219.X

A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01219.X

Epidemiology of hip fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01219.X

Adverse effects of oral corticosteroids in relation to dose in patients with lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01219.X

Use of oral corticosteroids in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01219.X

Public health impact of adverse bone effects of oral corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01219.X

Oral corticosteroids and fracture risk: relationship to daily and cumulative doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01219.X

Molecular mechanisms of glucocorticoid-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01219.X

Alcohol intake, beverage preference, and risk of hip fracture in men and women. Copenhagen Centre for Prospective Population Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01219.X

Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01219.X

10.1046/J.1365-2796.2003.01219.X

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference